Aprea Therapeutics, Inc. · CIK 1781983
Aprea Therapeutics, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Dec 29, 2025
through Dec 29, 2025
through Dec 29, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $5,783,766
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $3,055,822
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Same reported sales compensation recipient
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- American Resources Corp · CIK 1590715
- Capital B S.A. · CIK 2141268
- Crossject SA · CIK 2136893
- Datavault AI Inc. · CIK 1682149
- DDC Enterprise Ltd · CIK 1808110
Form D filings (1)
-
0001781983-25-000003D · Dec 29, 2025 · BiotechnologyOffering: $5,783,766Sold: $3,055,822